info
Thank you for visiting CancerPPD.

Browse Result page of CancerPPD


This page gives details of Query peptides and provides facility to browse the same in CancerPPD database. Please wait while data is being retrieved. For more information see HELP page.




IDPMIDSEQUENCENAME LENGTHACTIVITY
103314499271FLPLLAGLAANFLPTIICKISYKCGGN624IC50=4.88 µg/ml
103414499271LLAGLAANFLPTIICKISYKCPTP121IC50=>100 µg/ml
103514499271FAGLAANFLPTIICKISYKCPTP220IC50=>100 µg/ml
103614499271FLKLLKKLAAKFLPTIICKISYKCPTP424IC50=18.1 µg/ml
103714499271FLKLLKKLAAKLFPTP513IC50=5.43 µg/ml
103814499271FLKLLKKLAAKLFPTP613IC50=17.56 µg/ml
103914499271FLGALFKALSKLLPTP713IC50=5.25 µg/ml
104014499271FLKLLAGLLKNFAPTP813IC50=32.23 µg/ml
105918617323RAGLQFPVGRLLRRLLRRLLRBuforin IIb21IC50=15.1 µg/ml
106018617323RAGLQFPVGRLLRRLLRRLLRBuforin IIb21IC50=11.5 µg/ml
106118617323RAGLQFPVGRLLRRLLRRLLRBuforin IIb21IC50=11.3 µg/ml
106218617323RAGLQFPVGRLLRRLLRRLLRBuforin IIb21IC50=11.7 µg/ml
106318617323RAGLQFPVGRLLRRLLRRLLRBuforin IIb21IC50=11.3 µg/ml
106418617323RAGLQFPVGRLLRRLLRRLLRBuforin IIb21IC50=10.6 µg/ml
106518617323RAGLQFPVGRLLRRLLRRLLRBuforin IIb21IC50=12.9 µg/ml
106618617323RAGLQFPVGRLLRRLLRRLLRBuforin IIb21IC50=23.9 µg/ml
111912005420KWKLFKKIPKFLHSAKKFCA-MA-P18IC50=20 µM
112012005420KWKFKKIPKFLHLAKKFP1817IC50=8 µM
112112005420KWKLFKKILKFLHLAKKF[L9]-P1818IC50=3 µM
112212005420KWKLFKKISKFLHLAKKF[S9]-P1818IC50=4 µM
112312005420WKLFKKIPKFLHLAKKFN-117IC50=9.5 µM
112412005420FKLFKKIPKFLHLAKKFN-217IC50=11 µM
112512005420KWFKKIPKFLHLAKKFN-316IC50=17 µM
112612005420WFKKIPKFLHLAKKFN-415IC50=32 µM
112712005420WKKIPKFLHLAKKFN-514IC50=100. <µM
112812005420WFKKIPKFLHLLKKFN-3L15IC50=5 µM
112912005420WKKIPKFLHLLKKFN-4L14IC50=5 µM
113012005420WKKIPKFLHLLKKFN-5L14IC50=17 µM
113112005420KWKLFKKIPFLHLAKKFC-117IC50=26 µM
113212005420KWKLFKKIPKFLHLAKKC-217IC50=38 µM
113312005420KWKLFKKIPLHLAKKFC-316IC50=79 µM
113412005420KWKLFKKIPKFLHLAKC-416IC50=54 µM
113512005420KWKLFKKIPHLAKKFC-515IC50=100 µM
113612005420KWKLFKKIPKFLHLAC-615IC50=47 µM
113712005420KWKLFKKIPLAKKFC-714IC50=100. <µM
113812005420KWKLFKKIPKFLHLC-814IC50=83 µM
113912005420KWKLFKKIPLKKFC-913IC50=100. <µM
114012005420KWKLFKKIPKFLHC-1013IC50=100. <µM
119710675500KWKLFKKIGIGKFLHSAKKFCA-MA20IC50=44 µM
119810675500KWKLFKKIKFLHSAKKFCA-MA117IC50=100 µM
119910675500KWKLFKKIPKFLHSAKKFCA-MA218IC50=28 µM
120010675500KWKLFKKIGPGKFLHSAKKFCA-MA320IC50=>100 µM
12327849420KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALCecropin B35IC50=24.8 µM
12367849420SWLSKTAKKLENSAKKRISEGIAIAIQGGPRCecropin P131IC50=>100 µM
12407849420MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVGShiva-138IC50=56 µM
12487849420KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALCecropin B35IC50=42.5 µM
12517849420KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALCecropin B35IC50=24.5
125210951191GLFDIIKKIAESFAurein1.213LC50 = 10 µM
126110951191GLFDIVKKVVGAFGSLAurein2.516LC50 = 10 µM
127010951191GLFDIAKKVIGVIGSLAurein2.616LC50 = 10 µM
127910951191GLFDIVKKIAGHIAGSIAurein 3.117LC50=10-100 µM
128810951191GLFDIVKKIAGHIASSIAurein 3.217LC50 = 10 µM
129710951191GLFDIVKKIAGHIVSSIAurein 3.317LC50 = 10 µM
14021708887, 2285300GIGKFLHAAKKFAKAFVAEIMNSMagainin B23IC50=37 µg/ml
14031708887, 2285300GIGKFLHSAKKFAKAFVAEIMNSMagainin G23IC50=42 µg/ml
14041708887, 2285300AIGKFLHSAKKFGKAFVGEIMNSMagainin A23IC50=49 µg/ml
14051708887, 2285300ALSKALSKALSKALSKALSKALSKZ4424Not Available
14061708887, 2285300ALSKALSKALSKALSKALSKALSKZ2424Not Available
14071708887, 2285300GIGKFLHSAKKFGKAFVGEIMNSMagainin 223IC50 >200 µg/ml
146521252288KWKSFAKTFKSAKKTVAHTALKAISSL6A/L17A26IC50=>83.6 µMo/L
146621252288KWKSFLKTFKSAKKTVAHTAAKAISSL17A/L21A26IC50=>83.6 µMo/L
146721252288KWKSFLKTFKSAKKTVAHTALKAISSL17A26IC50=>83.6 µMo/L
146821252288KWKSFLKTFKSAKKTVAHTAAKAISSL21A26IC50=70.8 µMo/L
146921252288KWKSFAKTFKSAKKTVLHTALKAISSL6A26IC50=62.3 µMo/L
147021252288KWKSFLKTFKSAKKTVLHTALKAISSP26IC50=15.8 µMo/L
147121252288KWKSFLKTFKSLKKTVLHTALKAISSA12L26IC50=5 µMo/L
147221252288KWKSFLKTFKSAKKTVLHTLLKAISSA20L26IC50=5.1 µMo/L
147321252288KWKSFLKTFKSLKKTVLHTLLKAISSA12L/A20L26IC50=6.2 µMo/L
147421252288KWKSFLKTFKSLKKTVLHTLLKLISSA12L/A20L/A23L26IC50=5.7 µMo/L
161912366526PEWFKCRRWQWRMKKLGAL118IC50=>404 µM
162012366526PAWFKARRWAWRMKKLAAL218IC50=>254 µM
162112366526PAWRKAFRWAWRMKKLAAL318IC50=18 µM
162212366526PAWFKARRWAWRMLKKAAL418IC50=16 µM
162312366526PAWRKAFRWAWRMLKKAAL518IC50=8 µM
162412366526PAWRKAFRWAARMLKKAAL618IC50=12 µM
162512366526PAWRKAFRAAWRMLKKAAL718IC50=11 µM
162612366526PAWAKAFRAAARMKLKAAL818IC50=87 µM
162712366526PAWRKAARWAWRMLKKAAL918IC50=32 µM
162812366526PAARKAFRWAWRMLKKAAL1018IC50=20 µM
162912366526PAARKAARWAWRMLKKGAL1118IC50=75 µM
163012366526PAWRKAFRWAKRMLKKAAL1218IC50=10 µM
163112366526PAWRKAFRKAWRMLKKAAL1318IC50=12 µM
163212366526PAWRKARRWAWRMKKLAAL1418IC50=141 µM
163312366526PAWRKARRWARRMKKLAAL1518IC50=92 µM
170222641352LLRHVVKILEKYLTemporin-La1324.15Inhibition ratio at 50 µg/ml
170322641352LLRHVVKILSKYLTemporin-Las1327.99 Inhibition ratio at 50 µg/ml
170422641352RGDLLRHVVKILEKYLRGD-La1619.76 Inhibition ratio at 50 µg/ml
170522641352RGDLLRHVVKILSKYLRGD-Las1629.33 Inhibition ratio at 50 µg/ml
17069614066ALWKNMLKGIGKLAGQAALGAVKTLVGADRS B328Cytotoxicity =12 µM
17079614066ALWKDILKNVGKAAGKAVLNTVTDMVNQDRS B428Cytotoxicity =15 µM
17089614066ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQDRS S135Not Available
1773NoneFALALKALKKALKKLKKALKKALHecate Ac23LD50 =54 µg/ml
1774NoneFALALKALKKALKKLKKALKKALHecate AM23LD50 =23 µg/ml
1775NoneMPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALGSB-37 AC38LD50 =175 µg/ml
1776NoneMPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALGSB-37 AM38LD50 =540 µg/ml
1777NoneFAKKLAKKLKKLAKKLAKLALALSHIVA 10 AC23LD50 =>1000 µg/ml
1778NoneFALAAKALKKLAKKLKKLAKKALFLAK01 AM23LD50 =62 µg/ml
1779NoneFALALKALKKLLKKLKKLAKKALFLAK03 AM23LD50 =26 µg/ml
1780NoneFALALKALKKLAKKLKKLAKKALFLAK04 AM23LD50 =10 µg/ml
1781NoneFALAKLAKKAKAKLKKALKALFLAK05 AM21LD50 =74 µg/ml
1782NoneFALALKALKKLKKALKKALFLAK06 AM19LD50 =14 µg/ml
1783NoneFALALKALKKLKKALKKALFLAK06 AC19LD50 =65 µg/ml
1784NoneFAKKLAKKLKKLAKLALALFLAK06 R-AC19LD50 =140 µg/ml
1785NoneVALALKALKKALKKLKKALKKALKAL V23LD50 =72 µg/ml
1786NoneFALALKKALKALKKALFLAK 17 AM16LD50 =21 µg/ml
1787NoneFAKKLAKLAKKLAKLALFLAK 26 AM17LD50 =9 µg/ml
1788NoneFAKKLAKLAKKLAKLALALFLAK 25 AM19LD50 =9 µg/ml
1789NoneFALALKALKKALkkLKKALKKALHECATE 2DAc23LD50 =14 µg/ml
1790NoneFAKKLAKLAKKLLALFLAK43 AM15LD50 =17 µg/ml
1791NoneFAKKLAKLAKKALALFLAK44 AM15LD50 =130 µg/ml
1792NoneFALAKKALKKAKKALFLAK62 AM15LD50 =760 µg/ml
1793NoneFAKKLAKKLKKLAKLALAKFLAK 06R-AM19LD50 =98 µg/ml
1794NoneGIGKFLKKAKKFGKAFVKILKKMSI-78 AM22LD50 =31 µg/ml
1795NoneFAKLLAKLAKKLLFLAK5013LD50 =9 µg/ml
1796NoneFAKKLAKLALKLAKLFLAK5115LD50 =140 µg/ml
1797NoneFAKKLAKKLAKLALFLAK5714LD50 =260 µg/ml
1798NoneFAKKLKKLAKLAKKLFLAK7115LD50 =300 µg/ml
1799NoneFAKKALKALKKLFLAK7712LD50 =575 µg/ml
1800NoneVAKLLAKLAKKLLFLAK50V13LD50 =23 µg/ml
1801NoneFAKLLAKLAKKLFLAK50F12LD50 =40 µg/ml
1802NoneVAKKLAKLAKKLAKLALFLAK26V AM17LD50 =32 µg/ml
1803NoneKWKLFKKIGAVLKVLCAME-1515LD50 =45 µg/ml
1804NoneFAKLLAKLAKKALFLAK50C13LD50 =60 µg/ml
1805NoneFAKLLAKALKKLLFLAK50D13LD50 =16 µg/ml
1806NoneFAKLLKLAAKKLLFLAK 50E13LD50 =500 µg/ml
1807NoneFAKLLAKKLLFLAK8010LD50 =>1000 µg/ml
1808NoneFAKKLAKALLFLAK8110LD50 =>1000 µg/ml
1809NoneFAKKLAKKLLFLAK8210LD50 =31 µg/ml
1810NoneFAKLAKKLLFLAK83M9LD50 =>1000 µg/ml
1811NoneFAKKLAKLAKKLAKLALFLAK 26 Ac17LD50 =105 µg/ml
1812NoneILPWKWPWWPWRRIndolicidin13LD50 =64 µg/ml
1813NoneFAKALKALLKALKALFLAK 17 C15LD50 =80 µg/ml
1814NoneFAKLLAKLAKAKLFLAK 50H13LD50 =475 µg/ml
1815NoneFAKLLAKLAKLKLFLAK 50G13LD50 =90 µg/ml
1816NoneFAKKLAKKLKKLAKKLAKKWKLSHIVA DERIV P69 + KWKL22LD50 =44 µg/ml
1817NoneFAKKLAKKLKKLAKKLAKShiva 10(1-18 AC)18LD50 =190 µg/ml
1818NoneFAKKLAKKLKKLAKKLAKKWKLSHIVA 10 PEPTIDE 71 + KWKL22LD50 =93 µg/ml
1819NoneKWKLFKKKTKLFKKFAKKLAKKLCA (1-7) Shiva10 (1-16)23LD50 =150 µg/ml
1820NoneFAKKLAKKLAKALFLAK 5413LD50 =465 µg/ml
1821NoneFAKKLAKKLAKLLFLAK 5613LD50 =42 µg/ml
1822NoneFAKKLAKKLAKAALFLAK 5814LD50 =970 µg/ml
1823NoneFAKKLAKKAKLAKKLFLAK 7215LD50 =>1000 µg/ml
1824NoneFAKKLKKLAKKLFLAK 7512LD50 =540 µg/ml
1825NoneKTKLFKKFAKKLAKKLKKLAKKLSHIVA 10 (1-16) Ac23LD50 =29 µg/ml
1826NoneKWKLFKKKTKLFKKFAKKLAKKLCA(1-7) Shiva10(1-16)-COOH23LD50 =63 µg/ml
1827NoneILPWKWPWWPWRRIndolocidin-ac13LD50 =12 µg/ml
1828NoneFAKALAKLAKKLLFLAK50B13LD50 =23 µg/ml
1829NoneFAKLLALALKLKLFLAK50I13LD50 =65 µg/ml
1830NoneFAKLLAKLAKAKAFLAK50K13LD50 =>1000 µg/ml
1831NoneFAKLLAKLAKAKGFLAK50L13LD50 =>1000 µg/ml
1832NoneFAKKLAKKLKKLAKKLAKLALALKALALKALShiva-1131LD50 =96 µg/ml
1833NoneFAKKLAKKLKKLAKKLIGAVLKVSHIVA 11[(1-16)ME(2-9]-COOH23LD50 =95 µg/ml
1834NoneFAKLLAKALKLKLFLAK 50N13LD50 =250 µg/ml
1835NoneFAKLLAKALKKALFLAK 50O13LD50 =60 µg/ml
1836NoneFAKLLAKALKKLFLAK 50P12LD50 =46 µg/ml
1837NoneKWKLFKKALKKLKKALKKALCA(1-& HECATE(11/23)20LD50 =11 µg/ml
1838NoneKIAKVALAKLGIGAVLKVLTTGLPYL-ME23LD50 =635 µg/ml
1839NoneFAKKLAKLAKKLFLAG26-D112LD50 =620 µg/ml
1840NoneMPKEKVFLKIEKMGRNIRNVISHNU319LD50 =>1000 µg/ml
1841NoneGIGAVLKVLTTGLPALISWIKRKRQQMELITTIIN26LD50 =9 µg/ml
1842NoneFAKKLAKLAKKLAKALFLAK26-D216LD50 =>1000 µg/ml
1843NoneFAKKLLAKALKLFLAG26-D312LD50 =180 µg/ml
1844NoneFAKFLAKFLKKALFLAK50 Q113LD50 =35 µg/ml
1845NoneFAKLLFKALKKALFLAK50 Q213LD50 =500 µg/ml
1846NoneFAKLLAKFLKKALFLAK50 Q313LD50 =150 µg/ml
1847NoneFAKLLAKAFKKALFLAK50 Q413LD50 =730 µg/ml
1848NoneFAKLFAKAFKKALFLAK50 Q513LD50 =>1000 µg/ml
1849NoneFAKLLAKALKKFLFLAK50 Q613LD50 =70 µg/ml
1850NoneFAKLLAKALKKFALFLAK50 Q714LD50 =54 µg/ml
1851NoneFAKLLAKLAKKFALFLAK50 Q814LD50 =730 µg/ml
1852NoneFAKLFAKLAKKFALFLAK50 Q914LD50 =400 µg/ml
1853NoneFKLAFKLAKKAFLFLAK50 Q1013LD50 =360 µg/ml
1854NoneFAKLLAKLAKFLAK50 T110LD50 =615 µg/ml
1855NoneFAKLLAKLAKKVLFLAK50 T213LD50 =18 µg/ml
1856NoneFAKLLAKLAKKILFLAK50 T313LD50 =90 µg/ml
1857NoneFAKLLAKLAKKELFLAK50 T413LD50 =>1000 µg/ml
1858NoneFAKLLAKLAKKSLFLAK50 T513LD50 =440 µg/ml
1859NoneFAKLAFLAK905LD50 =500 µg/ml
1860NoneFAKLFFLAK915LD50 =>1000 µg/ml
1861NoneKAKLFFLAK925LD50 =>1000 µg/ml
1862NoneKWKLFFLAK935LD50 =600 µg/ml
1863NoneFGKGIGKVGKKLLFLAK50 Z113LD50 =>1000 µg/ml
1864NoneFAFGKGIGKVGKKLLFLAK50 Z215LD50 =>1000 µg/ml
1865NoneFAKAIAKIAFGKGIGKVGKKLLFLAK50 Z322LD50 =>1000 µg/ml
1866NoneFAKLWAKLAFGKGIGKVGKKLLFLAK50 Z422LD50 =54 µg/ml
1867NoneFAKLWAKLAKKLFLAK50 Z512LD50 =500 µg/ml
1868NoneFAKGVGKVGKKALFLAK50 Z613LD50 =>1000 µg/ml
1869NoneFAFGKGIGKIGKKGLFLAK50 Z715LD50 =>1000 µg/ml
1870NoneFAKIIAKIAKIAKKILFLAK50 Z816LD50 =625 µg/ml
1871NoneFAFAKIIAKIAKKIIFLAK50 Z915LD50 =>1000 µg/ml
1872NoneFALALKAFLAK947LD50 =430 µg/ml
1873NoneKWKLAKKALALLFLAK93B12LD50 =44 µg/ml
1874NoneFAKIIAKIAKKIFLAK50 Z1012LD50 =>1000 µg/ml
1875NoneFALALKALKKALFLAK9612LD50 =150 µg/ml
1876NoneFALKALKKFLAK978LD50 =>1000 µg/ml
1877NoneKYKKALKKLAKLLFLAK9813LD50 =110 µg/ml
1878NoneFKRLAKIKVLRLAKIKRFKRLA17LD50 =106 µg/ml
1879NoneFAKLAKKALAKLLFLAK91B13LD50 =315 µg/ml
1880NoneKAKLAKKALAKLLFLAK92B13LD50 =>1000 µg/ml
1881NoneKLALKLALKALKAAKLAFLAK9917LD50 =160 µg/ml
1882NoneFAKLLAKLAKKFLAK50T611LD50 =>1000 µg/ml
1883NoneFAKLLAKLAKKGLFLAK50T713LD50 =430 µg/ml
1884NoneFALKALKKLKKALKKALFLAK9517LD50 =64 µg/ml
1885NoneVAKLLAKLAKKVLFLAK50T813LD50 =315 µg/ml
1886NoneYAKLLAKLAKKALFLAK50T913LD50 =>1000 µg/ml
1887NoneKLLKLLLKLYKKLLKLLFLAK100-CO2H17LD50 =135 µg/ml
1888NoneFAVGLRAIKRALKKLRRGVRKVAKDLFAGVL26LD50 =240 µg/ml
1889NoneKLAKKLAKLAKLAKALModelin-516LD50 =61 µg/ml
1890NoneKLAKKLAKLAKLAKALModelin-5-CO2H16LD50 =320 µg/ml
1891NoneFALALKALKKLFLAK1209LD50 =360 µg/ml
1892NoneFALAKALKKALFLAK12111LD50 =>1000 µg/ml
1893NoneFALALKLAKKALFLAK96B12LD50 =230 µg/ml
1894NoneFALLKLFLAK96G6LD50 =630 µg/ml
1895NoneFALALKALKKFLAK96F10LD50 =510 µg/ml
1896NoneFALKALKKALFLAK96C10LD50 =940 µg/ml
1897NoneFALLKALKKALFLAK96D11LD50 =305 µg/ml
1898NoneKFKKLAKKFModelin-8D9LD50 =>1000 µg/ml
1899NoneKFKKLAKKWModelin-8E9LD50 =>1000 µg/ml
1900NoneFALALKALKKAFlak 96H11LD50 =>1000 µg/ml
1901NoneFALLKALLKKALFlak 96I12LD50 =190 µg/ml
1902NoneFALALKLAKKLFlak 96J11LD50 =770 µg/ml
1903NoneLKKLAKLALAFFlak 96L11LD50 =555 µg/ml
1904NoneVALALKALKKLFLAK-120G11LD50 =950 µg/ml
1905NoneFALALKLKKLFLAK-120D10LD50 =550 µg/ml
1906NoneFALALKAKKLFLAK-120C10LD50 =>1000 µg/ml
1907NoneFALAFLAK-120B4LD50 =>1000 µg/ml
1908NoneWALALFLAK-120F5LD50 =260 µg/ml
1909NoneGIGKFLHAAKKFAKAFVAEIMNSMagainin2wisc23LD50 =22 µg/ml
1910NoneFAKKFAKKFKKFAKKFAKFAFAFD2A2123LD50 =64 µg/ml
1911NoneKKVVFKVKFKKSL-110LD50 =340 µg/ml
1912NoneFKVKFKVKVKKSL-710LD50 =315 µg/ml
1913NoneLPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALGLSB-3738LD50 =50 µg/ml
1914NoneFAKKLAKKLKKLAKKLAKLAKKLAnubis-223LD50 =38 µg/ml
1915NoneFAKKLAKLAKKLAKLALALFLAK 17 CV19LD50 =23 µg/ml
1916NoneVAKFLAKFLKKALFLAK50 Q1V13LD50 =92 µg/ml
1917NoneVAKKFAKKFKKFAKKFAKFAFAFD2A21V23LD50 =210 µg/ml
1918NoneVAKKLAKLAKKLAKLALALFLAK 25 AM V19LD50 =130 µg/ml
1919NoneVAKKLAKLAKKLLALFLAK43 AM V15LD50 =86 µg/ml
1920NoneVAKLLAKALKKLLFLAK50D V13LD50 =45 µg/ml
1921NoneVALALKALKKALKKLKKALKKALHecate AM V23LD50 =340 µg/ml
1922NoneVALALKALKKALKKLKKALKKALHecate AC V23LD50 =160 µg/ml
1923NoneVALALKALKKLAKKLKKLAKKALFLAK04 AM V23LD50 =84 µg/ml
1924NoneFAKLLAKLAKKAAFLAK50J13Not Available
281623000474RRRRRNWMWC9R10IC50=39 µM
281723000474RRRRRWCMNW9S1R10IC50=18 µM
281823000474RRRRRNWMWC9R10IC50=29 µM
281923000474RRRRRWCMNW9S1R10IC50=12 µM
282023000474RRRRRNWMWC9R10IC50=16 µM
282123000474RRRRRWCMNW9S1R10IC50=10 µM
284923028527GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAVAdenoregulin33GI50 =8.06±0.50 µM
285123577112, 21871946FVDLKKIANIINSIFTempoprin-1CEa1522% Cell viability at 40 µM
285223577112, 21871946FVDLKKIANIINSIFTempoprin-1CEa1561% Cytotoxicity at 40 µM
285323577112, 21871946FVDLKKIANIINSIFTempoprin-1CEa1561% Cell viability at 40 µM
285423577112, 21871946FVDLKKIANIINSIFTempoprin-1CEa1532% Cytotoxicity at 40 µM
286122084165KLlLKlLkkLLKlLKKKLytik17IC50=18.5 µMol/L
286822084165KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKKIL-4RaÐlytic hybrid peptide33IC50=5.7 µMol/L
287223583573DEVDcaspase 3 inhibitor465% Cell viability at 20 µM
287323583573DEVDcaspase 3 inhibitor440% Cell viability at 30 µM
287423583573DEVDcaspase 3 inhibitor435 % Cell viability at 40 µM
287523583573FVDLKKIANIINSIFTempoprin-1CEa1570% Cell viability at 20 µM
287623583573FVDLKKIANIINSIFTempoprin-1CEa1545% Cell viability at 30 µM
287723583573FVDLKKIANIINSIFTempoprin-1CEa1530 % Cell viability at 40 µM
288020212453KWKLFKKIGAVLKVLCamel15LC50 = 6.2 µM
290121849092KLlLKlLkkLLKlLKKKLytik17IC50= 34.5 µM
290221849092KLlLKlLkkLLKlLKKKLytik17IC50= 14.1 µM
290321849092KLlLKlLkkLLKlLKKKLytik17IC50= 25.7 µM
290421849092KLlLKlLkkLLKlLKKKLytik17IC50= 27.0 µM
290521849092KLlLKlLkkLLKlLKKKLytik17IC50= 20.0 µM
290621849092KLlLKlLkkLLKlLKKKLytik17IC50= 19.4 µM
291321849092THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKKTransferrin receptor (TfR)-lytic hybrid peptide32IC50= 8.8 µM
291421849092THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKKTransferrin receptor (TfR)-lytic hybrid peptide32IC50= 4.0 µM
291521849092THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKKTransferrin receptor (TfR)-lytic hybrid peptide32IC50= 6.5 µM
291621849092THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKKTransferrin receptor (TfR)-lytic hybrid peptide32IC50= 7.8 µM
291721849092THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKKTransferrin receptor (TfR)-lytic hybrid peptide32IC50= 4.8 µM
291821849092THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKKTransferrin receptor (TfR)-lytic hybrid peptide32IC50= 9.3 µM
309616004618MRKEFHNVLSSGQLLADKRPARDYNRKPep2727IC50= >70 µM
309716004618MWKWFHNVLSSWQLLADKRPARDYNRKPep27anal127IC50= 55 µM
309816004618MWKWFHNVLSWWWLLADKRPARDYNRKPep27anal227IC50= <10 µM
309916004618MRKWFHNVLSSGQLLADKWPAWDYNRKPep27anal327IC50= 38 µM
310016004618MWKEFHNVLSSGQLLADKRWARWYNRWPep27anal427IC50= 29 µM
310116004618MWKWFHNVLSSGQLLADKWWAWWYNWWPep27anal527IC50=>70 µM
311423993331KWLRRVWRWWRMAP-04-0311Cell viability >80% at 25 µM
311523993331KWLRRVWRWWRMAP-04-0311Cell viability ~50% at 50 µM
311623993331KWLRRVWRWWRMAP-04-0311Cell viability <40% at 75 µM
311723993331KWLRRVWRWWRMAP-04-0311Cell viability >20% at 100 µM
311823993331KWLRRVWRWWRMAP-04-0311Cell viability ~100% at 25 µM
311923993331KRLRRVWRRWRMAP-04-0411Cell viability >80% at 50 µM
312023993331KRLRRVWRRWRMAP-04-0411Cell viability >80% at 75 µM
312123993331KRLRRVWRRWRMAP-04-0411Cell viability >80% at 100 µM
312223993331KWLRRVWRWWRMAP-04-0311IC50=61.5 µM
312723770440FLGMIPGLIGGLISAFKTsAP-217IC50 = 6.4 µM
313223770440FLSLIPKLVKKIIKAFKTsAP-S117IC50 = 1.8 µM
313723770440FLGMIPKLIKKLIKAFKTsAP-S217IC50 = 1.8 µM
316023301519WRWRWRWRWCyclic [W(RW)4 ]-Dox960-79% inhibition of cell proliferation at 1 µM
316423301519RWRWRWRWlinear (RW)4-Dox860-74% antiproliferative activity at 1 µM
319117787026(K-Aib-C(CH2CO-2'-Pac))4Dimer of peptide-paclitaxel conjugate3IC50 =0.62nM
319417787026(K-Aib-C(CH2CO-2'-Pac))3Trimer of peptide-paclitaxel conjugate3IC50 =3.00nM
319717787026(K-Aib-C(CH2CO-2'-Pac))4Tetramer of peptide-paclitaxel conjugate3IC50 =0.64nM
321622413859KVKVKVKVpPTKVKVKVKSVS-118IC50 =8.1±0.8 µM
321722413859KVKVKVKVpPTKVKVKVKSVS-118IC50 =5.6±0.5 µM
322022413859kvkvkvkvPptkvkvkvkD-SVS-118IC50 =4.7±0.4 µM
322122413859kvkvkvkvPptkvkvkvkD-SVS-118IC50 =3.2±0.4 µM
322422413859KVKVKVKVPPTKVKVKVKSVS-218IC50 >100 µM
322522413859KVKVKVKVPPTKVKVKVKSVS-218IC50 >100 µM
326918815734VRRFPWWWPFLRRTritrpticin13IC50 =142 µg/ml
327218815734KKKFPWWWPFKKKPST13-RK13IC50 =80 µg/ml
327518815734KKKFPWWWPFKKKCKKKFPWWWPFKKKCdi-PST13-RK-C28IC50 =17 µg/ml
327818815734KKKFPWWWPFKKKKKKFPWWWPFKKKKdi-PST13-RK-K27IC50 =10 µg/ml
330621453492WKKW-Dip-KKWKLTX-3029IC50 =73 ± 2 µM
330921453492KKWWKKW-Dip-KLTX-3159IC50 =31 ± 3 µM
331221453492OOW-Dip-OOWWOLTX-3189IC50 =216 ± 36 µM
331521453492, 23533710FKCRRWQWRMKKLfcinB12IC50 > 160 µM
381622963485MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG
AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ
NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLAN
NFVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRA
FKQL		wtmda-7/IL-24206Cell viability(% of control)=0.5 at concentration 7 µg/ml
381822963485MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG
AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ
NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANN
FVLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAF
KQLDVEAALTKALGEVDILLTWMQKFYKL		RGD-mda-7207Cell viability(% of control)=0.5 at concentration 4 µg/ml
382022963485MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG
AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ
NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANN
FVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAF
KQL		wtmda-7/IL-24206Apoptotic rate(%)= >50% at concentration of 8 µg/ml
382322963485MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG
AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ
NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNF
VLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAFK
QLDVEAALTKALGEVDILLTWMQKFYKL		RGD-mda-7207Apoptotic rate(%)= >70% at concentration of 8 µg/ml
387016722632YA*822.4% inhibition at 10-5
387116722632YA*827.5% inhibition at 10-4
389416722632YSA*931.1% inhibition at 10-5
389516722632YSA*931.2% inhibition at 10-4
389616722632YSA*9317.8% inhibition at 10-3
391516722632YSA*1037.7% inhibition at 10-4M
391616722632YSA*10318.7% inhibition at 10-3M
394116722632YSA*G15421.2% inhibition at 10-3M
396516722632YRA*G16415.6% inhibition at 10-3M
399016722632YA*GFM17522.8% inhibition at 10-3M
401516722632YA*GFM1859.6% inhibition at 10-4M
401616722632YA*GFM18529.9% inhibition at 10-3M
402616722632YGGFMA*2362.2% inhibition at 10-6M
402716722632YGGFMA*2367.1% inhibition at 10-5M
402816722632YGGFMA*2366.9% inhibition at 10-4M
402916722632YGGFMA*23625.9% inhibition at 10-3M
403812631273, 9266696GLFDVIKKVASVIGGLCitropin 1.116IC50= 5 M
404712631273, 9266696glfdvikkvasvigglCitropin 1.1D16IC50= 5 M
405612631273, 9266696GLFAVIKKVASVIGGL316IC50= 6 M
406512631273, 9266696GLFDVIKAVASVIGGL516IC50= 5 M
407412631273, 9266696GLFDVIKKVAAVIGGL716IC50= 5 M
408312631273, 9266696GLFDVIKKVASVIKGL1116IC50= 5 M
409212631273, 9266696GLFDVIKKVASVIKKL1316IC50= 5 M
410112631273, 9266696GLFDVIAKVASVIKKL1416IC50= 5 M
411012631273, 9266696GLFAVIKKVASVIKGL1516IC50= 5 M
411912631273, 9266696GLFAVIKKVASVIKKL1616IC50= 5 M
412812631273, 9266696GLFAVIKKVAAVIKKL1716IC50= 5 M
413712631273, 9266696GLFAVIKKVAAVIRRL1816IC50= 5 M
414612631273, 9266696GLFAVIKKVAKVIKKL1916IC50= 5 M
415512631273, 9266696GLFKVIKKVASVIGGL2216IC50= 5 M
416412631273, 9266696GLFKVIKKVAKVIKKL2316IC50= 5 M
417312631273, 9266696LGGIVSAVKKIVDFLGretro16IC50= >10 µM
4336NoneYHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKKEB-Lytic32IC50= 6.5 µM
4342NoneYRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKKEB(H2R)-lytic32IC50= 1.9 µM
4349NoneNYQWVPYQGRVPYPRGGLLkLLKklLKKLlKLSema3A(aa363-377) -nLytic32IC50= 13.1 µM
4353NoneGRVPYPRGGLLkLLKklLKKLlKLSema3A(aa371-377) -nLytic24IC50= 14.1 µM
448522057278KAAKKWAKAAKKWAKAWKKAAZ121EC50 =186 µM
448622057278KAAKKWAKAWKKAAKAWKKAAZ221EC50 =173 µM
448722057278KAAKKAWKAWKKAAKAAWKKAAZ321EC50 =128 µM
448822057278KAAKKAWKAAKKAAKWWKKAAZ421EC50 =68 µM
448922057278KAAKKAWKWAKKAAKWAKKAAZ521EC50 =28 µM
449022057278KWWKKAAKAAKKAAKAAKKWAZ621EC50 =16 µM
449122057278KAAKKAWKAAKKAWKAAKKAAZ721EC50 =15 µM
449222057278AWKKWAKAWKWAKAKWWAKAAZ821EC50 =14 µM
449322057278AAWKWAWAKKWAKAKKWAKAAZ921EC50 =16 µM
449422057278AAKKWAKAKWAKAKKWAKAAZ1021EC50 >211 µM
451122023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-03265% cytotoxic at 5 µM
451222023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-03265% cytotoxic at 10 µM
451322023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032630-35% cytotoxic at 25 µM
451422023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032660% cytotoxic at 50 µM
451522023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-03265-10% cytotoxic at 5 µM
451622023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032610% cytotoxic at 10 µM
451722023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032630-35% cytotoxic at 25 µM
451822023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032660% cytotoxic at 50 µM
451922023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032630% cytotoxic at 5 µM
452022023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032650% cytotoxic at 10 µM
452122023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032670% cytotoxic at 25 µM
452222023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032680-85% cytotoxic at 50 µM
452322023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032630% cytotoxic at 5 µM
452422023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032640-50% cytotoxic at 10 µM
452522023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032660-70% cytotoxic at 25 µM
452622023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032680-85% cytotoxic at 50 µM
452722023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032615-20% cytotoxic at 5 µM
452822023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032640-50% cytotoxic at 10 µM
452922023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032680% cytotoxic at 25 µM
453022023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032685-90% cytotoxic at 50 µM
453122023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-0725~0% cytotoxic at 5 µM
453222023734RWGKWFKKATHVGKHVGKAALTAYLNRC-07255% cytotoxic at 10 µM
453322023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072520-30% cytotoxic at 25 µM
453422023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072540-50% cytotoxic at 50 µM
453522023734RWGKWFKKATHVGKHVGKAALTAYLNRC-0725~0% cytotoxic at 5 µM
453622023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072510% cytotoxic at 10 µM
453722023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072520% cytotoxic at 25 µM
453822023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072540-50% cytotoxic at 50 µM
453922023734RWGKWFKKATHVGKHVGKAALTAYLNRC-0725~0% cytotoxic at 5 µM
454022023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072520% cytotoxic at 10 µM
454122023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072570-80% cytotoxic at 25 µM
454222023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072580-85% cytotoxic at 50 µM
454322023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072510% cytotoxic at 5 µM
454422023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072550% cytotoxic at 10 µM
454522023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072580% cytotoxic at 25 µM
454622023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072580-90% cytotoxic at 50 µM
454722023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072530-40% cytotoxic at 5 µM
454822023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072560-70% cytotoxic at 10 µM
454922023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072580-90% cytotoxic at 25 µM
455022023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072585-90% cytotoxic at 50 µM
455122023734GWRTLLKKAEVKTVGKLALKHYLNRC-1323~5% cytotoxic at 10 µM
455222023734GWRTLLKKAEVKTVGKLALKHYLNRC-132310% cytotoxic at 25 µM
455322023734GWRTLLKKAEVKTVGKLALKHYLNRC-132310-15% cytotoxic at 50 µM
455422023734GWRTLLKKAEVKTVGKLALKHYLNRC-1323~0% cytotoxic at 5 µM
455522023734GWRTLLKKAEVKTVGKLALKHYLNRC-1323~0% cytotoxic at 10 µM
455622023734GWRTLLKKAEVKTVGKLALKHYLNRC-132310% cytotoxic at 25 µM
455722023734GWRTLLKKAEVKTVGKLALKHYLNRC-132310-15% cytotoxic at 50 µM
455822023734GWRTLLKKAEVKTVGKLALKHYLNRC-132310% cytotoxic at 5 µM
455922023734GWRTLLKKAEVKTVGKLALKHYLNRC-132310% cytotoxic at 10 µM
456022023734GWRTLLKKAEVKTVGKLALKHYLNRC-132310-15% cytotoxic at 25 µM
456122023734GWRTLLKKAEVKTVGKLALKHYLNRC-132315-20% cytotoxic at 50 µM
456222023734GWRTLLKKAEVKTVGKLALKHYLNRC-1323~5% cytotoxic at 5 µM
456322023734GWRTLLKKAEVKTVGKLALKHYLNRC-1323~5% cytotoxic at 10 µM
456422023734GWRTLLKKAEVKTVGKLALKHYLNRC-13235% cytotoxic at 25 µM
456522023734GWRTLLKKAEVKTVGKLALKHYLNRC-132310-15% cytotoxic at 50 µM
456622023734GWRTLLKKAEVKTVGKLALKHYLNRC-1323~0% cytotoxic at 5 µM
456722023734GWRTLLKKAEVKTVGKLALKHYLNRC-1323~0% cytotoxic at 10 µM
456822023734GWRTLLKKAEVKTVGKLALKHYLNRC-13235-10% cytotoxic at 25 µM
456922023734GWRTLLKKAEVKTVGKLALKHYLNRC-132320% cytotoxic at 50 µM
457022023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032670% cytotoxic at 50 µM
457122023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072570% cytotoxic at 50 µM
457222023734GWRTLLKKAEVKTVGKLALKHYLNRC-13230% cytotoxic at 50 µM
457322023734GRRKRKWLRRIGKGVKIIGGAALDHLNRC-032660-70% cytotoxic at 50 µM
457422023734RWGKWFKKATHVGKHVGKAALTAYLNRC-072560-70% cytotoxic at 50 µM
457522023734GWRTLLKKAEVKTVGKLALKHYLNRC-1323~5% cytotoxic at 50 µM
459921351323YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKKEGFR-lytic32IC50 =0.12 µM
460021351323YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKKEGFR-lytic32IC50 =0.46 µM
461220802991CSSRTMHHCPeptide-209at 100 µM 55% viablity
461920964334KWKWKWDex-(KW)36at 10 µM 35-40% viablity
467222885172GLFGKLIKKFGRKAISYAVKKARGKHLatarcin 2a26graph fig 8 A
500124587350GIGKFLKKAKKFGKAFVKILKKPexiganan22LC50= 8 at 100 µM
500224587350LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESLL 3737LC50= 21 at 100 µM
505824830845ETFSDWWKLLAEmt_L22 W/P27A12IC50=16.3 µM
505924830845LTFSDWWKLLAEmt_E17L/L22 W/P27A12IC50=15.1 µM
506024830845ESFSDWWKLLAEmt_T18S/L22 W/P27A12IC50=27 µM
506124830845ETFADWWKLLAEmt_S20A/L22 W/P27A12IC50= 8.7 µM